Cinchonidine induces muscle weakness by inhibiting insulin-mediated IRS-1-AKT signaling pathway
Journal of Microbiology · 2025
DOI: 10.71150/jm.2511017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Microbiology, 2025. Verfasst von Mi Ran Byun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Daegu Catholic University, Gyeongsan 38430, Republic of Korea. Hauptthemen laut MEDLINE: Insulin Receptor Substrate Proteins, Signal Transduction, Proto-Oncogene Proteins c-akt, Insulin. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Daegu Catholic University.
Abstract (Originalsprache)
Sarcopenia is an age-related condition marked by a reduction in muscle mass and strength, and it is associated with impaired muscle regeneration and differentiation. While diseases like cardiovascular and chronic liver disease can induce sarcopenia, there is limited evidence regarding the specific diseases and mechanisms responsible for its development. In skeletal muscle, the loss of muscle mass is accompanied by a decrease in myofilament proteins and the inhibition of muscle differentiation in satellite cells. Bioactive compounds obtained from natural products have been traditionally used as therapeutics for diverse conditions. In this report, we investigated the effect of cinchonidine (CD) extracted from Cinchona tree on muscle differentiation of mouse satellite cells, and myoblast cell lines. CD significantly inhibited muscle differentiation by suppressing myotube formation and gene expression of myogenesis markers. In addition, CD reduced muscle differentiation by blocking phosphorylation of insulin receptor substrate 1 (IRS-1) during insulin-induced signal transduction. Therefore, the results show that CD, an antimalarial agent, inhibited muscle differentiation through the suppression of IRS-1 phosphorylation, suggesting that sarcopenia can be induced by CD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Daegu Catholic University, Gyeongsan 38430, Republic of Korea.
- Department of Pharmacy, College of Pharmacy, Research Institute for Drug Development, Pusan National University, Busan 46241, Republic of Korea.
Förderung
- Daegu Catholic University
Zitieren
APA
Byun, M. R., Joo, S. H., Jung, Y. S., & Choi, J. S. (2025). Cinchonidine induces muscle weakness by inhibiting insulin-mediated IRS-1-AKT signaling pathway. Journal of Microbiology. https://doi.org/10.71150/jm.2511017
Vancouver
Byun MR, Joo SH, Jung YS, Choi JS. Cinchonidine induces muscle weakness by inhibiting insulin-mediated IRS-1-AKT signaling pathway. Journal of Microbiology. 2025. doi:10.71150/jm.2511017
BibTeX
@article{Byun2025,
author = {Byun, Mi Ran and Joo, Sang Hoon and Jung, Young-Suk and Choi, Joon-Seok},
title = {Cinchonidine induces muscle weakness by inhibiting insulin-mediated IRS-1-AKT signaling pathway},
journal = {Journal of Microbiology},
year = {2025},
doi = {10.71150/jm.2511017}
}
EUVIMED